A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

(2009) J W Valle et al.   BRITISH JOURNAL OF CANCER

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer

(2009) Takashi Sasaki et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Experimental study of combination therapy with S-1 against pancreatic cancer

(2009) Jun Yoshizawa et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

(2009) Narikazu Boku et al.   LANCET ONCOLOGY

Clinical Outcome of Gemcitabine/S-1 Combination Therapy for Advanced Pancreatic Cancer

(2009) Junichi Yamauchi et al.   PANCREAS

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study

(2008) Junji Furuse et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer

(2008) Chigusa Morizane et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Patient-Reported Outcomes of Patients With Advanced Biliary Tract Cancers Receiving Gemcitabine Plus Capecitabine: A Multicenter, Phase II Trial of the Swiss Group for Clinical Cancer Research

(2008) Dieter Koeberle et al.   JOURNAL OF CLINICAL ONCOLOGY